Prevention of severe perinatal hemolytic disease with intravenous immunoglobulin in a highly sensitized patient

Simple item page
dc.coverageDOI: 10.4067/S0717-75262021000100076
dc.creatorAndueza, Catalina Villalobos
dc.creatorBalmaceda, Manuel José Monckeberg
dc.creatorGonzález, Cristian Kottman
dc.creatorRocuant, Juan Carlos Arteaga
dc.creatorEbensperger, Enrique Oyarzún
dc.date2021
dc.date.accessioned05-01-2026 18:17
dc.date.available05-01-2026 18:17
dc.description<p>Perinatal Hemolytic Disease is uncommon today due to its prevention. However, there are cases of highly sensitized mothers who wish to have a child, that forces this desired pregnancy to be controlled in a special way and be subjected to invasive procedures not exempt from fetal morbidity and mortality. Prenatal use of human inmunoglobulin in the mother may represent a therapeutic alternative. We present a case in which its use prevented the development of intrauterine disease and favored a good neonatal evolution despite the fact that the initial prognosis was very adverse.</p>eng
dc.identifierhttps://investigadores.uandes.cl/en/publications/021c8899-528e-4ba6-99b2-e1e0966c8cc7
dc.languagespa
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcevol.86 (2021) nr.1 p.76-80
dc.subjectCordocentesis
dc.subjectImmunoglobulin
dc.subjectIntrauterine transfusion
dc.subjectPerinatal hemolytic disease
dc.subjectRh(D) isoinmmunization
dc.subjectSDG 3 - Good Health and Well-being
dc.titlePrevention of severe perinatal hemolytic disease with intravenous immunoglobulin in a highly sensitized patienteng
dc.titlePrevención de enfermedad hemolítica perinatal severa con inmunoglobulina intravenosa en paciente altamente sensibilizadaspa
dc.typeArticleeng
dc.typeArtículospa
Files
Collections
Clínica UANDES